SuperSonic Imagine Announces the Appointment of Bernard Doorenbos as President of Supervisory Board

Regulatory News:

SuperSonic Imagine (Paris:SSI) (Euronext: SSI, FR0010526814, PEA-PME eligible), a company specialized in ultrasound medical imaging, today announces the appointment of Bernard Doorenbos as Interim President and Hernmann Requardt as independent strategic consultant for SuperSonic Imagine’s Supervisory Board. Bernard Doorenbos is replacing Hans Barella, who is stepping down today, as previously announced at the Shareholders’ Meeting on March 3, 2014 and communicated in the last Reference Document.

Bernard Doorenbos began his career in 1983 at Phillips Group’s Medical Systems division, where he was Head of Sales and Services for Latin America, and then joined Thalès’ naval division in 1986. Following his impressive performance, Bernard Doorenbos has since spent most of his career in senior management in listed companies such as Axxicon Group, Neways Electronics and Vilenzo International, as well as at the helm of a number of industrial companies. Bernard Doorenbos, 66, has an MSc in Electronics from the Delft University of Technology and a Master’s degree in Financial Economics from the University of Amsterdam.

Bernard Doorenbos says: "I am very pleased to be joining SuperSonic Imagine’s Supervisory Board. Aixplorer’s clinical and technological added value are major assets that will, I am convinced, enable the Company to become a benchmark global player in the field of ultrasound medical imaging. I am looking forward to being able to help guide senior management’s innovation strategy and expansion plans of the Company’s sales structure globally.”

Hermann Requardt is appointed Independent Consultant to SuperSonic Imagine’s Supervisory Board and Board of Directors to provide his extensive expertise and substantial knowledge of the sector. Hermann Requardt, 60, began his career in 1984 at Siemens Medical Solutions as a physicist within the imaging division, and rose rapidly through the ranks. In 2008, he was appointed CEO of Siemens Healthcare and the Corporate Technology Department. Hermann Requardt is also active in academic circles and is notably an Honorary Professor of Physics at the prestigious Goethe University in Frankfurt, Germany.

Tom Egelund, Chairman of the Board, concludes: "We are delighted to welcome Bernard Doorenbos as President of SuperSonic Imagine’s Supervisory Board. His strategic expertise at the head of numerous listed companies and his industry knowledge represent exceptional assets for the Company. We would also like to wholeheartedly thank Hans Barella for his unwavering commitment and his invaluable contribution in helping make SuperSonic Imagine a leading player in the field of ultrasound medical imaging.”

SuperSonic Imagine

Founded in 2005 and based in Aix-en-Provence (France), SuperSonic Imagine is a company specializing in medical imaging. The company designs, develops and markets a revolutionary ultrasound system, Aixplorer®, with an UltraFast™ platform that can acquire images 200 times faster than conventional ultrasound systems. Aixplorer is the only system that can image two types of waves: ultrasound waves ensure excellent image quality and shear waves, which allow physicians to visualize and analyze the stiffness of tissue in a real-time, reliable, reproducible and non-invasive manner. This innovation, ShearWave™Elastography, significantly improves the detection and characterization of numerous pathologies in several applications including breast, thyroid, liver and prostate. SuperSonic Imagine has been granted regulatory clearances for the commercialization of Aixplorer in the main global markets. Over the past years, SuperSonic Imagine enjoyed the backing of several prestigious investors, among which Auriga Partners, Edmond de Rothschild Investment Partners, Bpifrance, Omnes Capital and NBGI.

For more information about SuperSonic Imagine, please go to www.supersonicimagine.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20150529005745/en/